Comorbidity Increases the Risk of Invasive Meningococcal Disease in Adults

被引:6
|
作者
Lundbo, Lene Fogt [1 ]
Harboe, Zitta Barrella [2 ,3 ,4 ]
Sandholdt, Hakon [1 ]
Smith-Hansen, Lars [5 ]
Valentiner-Branth, Palle [6 ]
Hoffmann, Steen [7 ]
Benfield, Thomas [1 ,4 ]
机构
[1] Copenhagen Univ Hosp Amager & Hvidovre, Ctr Res & Disrupt Infect Dis, Dept Infect Dis, Hvidovre, Denmark
[2] Copenhagen Univ Hosp North Zealand, Dept Pulm & Infect Dis, Copenhagen, Denmark
[3] Statens Serum Inst, Dept Microbiol Surveillance & Res, Copenhagen, Denmark
[4] Univ Copenhagen, Fac Hlth Sci, Dept Clin Med, Copenhagen, Denmark
[5] Copenhagen Univ Hosp Amager & Hvidovre, Dept Clin Res, Hvidovre, Denmark
[6] Statens Serum Inst, Dept Infect Dis Epidemiol & Prevent, Infect Dis Preparedness, Copenhagen, Denmark
[7] Statens Serum Inst, Dept Bacteria Parasites & Fungi, Infect Dis Preparedness, Copenhagen, Denmark
关键词
Neisseria meningitidis; sepsis; meningitis; comorbidity; IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; ASPLENIC PATIENTS; INFECTIONS; PREVENTION; RECOMMENDATIONS; IMMUNOGENICITY; VACCINES;
D O I
10.1093/cid/ciab856
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this Danish case-control-study that included >1200 cases over 4 decades, certain comorbidities increased risk of invasive meningococcal disease, ranging from a 2- to 40-fold increased risk. Vaccination and increased focus on appropriate medical care may be warranted in these populations. Background Risk of invasive meningococcal disease (IMD) is increased in patients with complement deficiency and human immunodeficiency virus (HIV) infection. Risk associated with comorbidity is not well described. Methods This was a nationwide adult case-control study. Cases for the period 1977-2018 were identified by the national meningococcus reference laboratory. Matched controls were identified by registry linkage. Comorbidities diagnosed prior to IMD were based on the International Classification of Diseases, Eighth or Tenth Revision. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated by logistic regression after adjustment for sex, age, and other comorbidities. Results We identified 1221 cases (45% male), with a median age of 45 years (interquartile range, 22-64 years). The dominant meningococcal serogroups were B (n = 738) and C (n = 337). Increased risk of IMD was associated with solid organ transplantation (SOT) (OR 40.47 [95% CI: 4.84-337.23]), hemolytic anemia (OR 7.56 [95% CI: 2.63-21.79]), renal disease (OR 2.95 [95% CI: 1.77-4.92]), liver disease (OR 2.54 [95% CI: 1.58-4.08]), cancer (OR 2.31 [95% CI: 1.85-2.89]), diabetes (OR 1.74 [95% CI: 1.27-2.39]), neurological disease (OR 1.72 [95% CI: 1.20-2.46]), and autoimmune disease (OR 1.70 [95% CI: 1.63-2.11]). Having 1, 2, and >= 3 comorbidities was associated with increased risk of IMD (ORs 1.6-3.5). Increased risk was not associated with specific serogroups. Conclusions This study of adults with IMD over 4 decades showed increased risk of IMD associated with renal disease, immunological disorders, liver disease, cancer, and SOT ranging from a 2- to 40-fold increased risk. Vaccination may be warranted in these populations.
引用
收藏
页码:125 / 130
页数:6
相关论文
共 50 条
  • [1] Influenza increases invasive meningococcal disease risk in temperate countries
    Salomon, A.
    Berry, I.
    Tuite, A. R.
    Drews, S.
    Hatchette, T.
    Jamieson, F.
    Johnson, C.
    Kwong, J.
    Lina, B.
    Lojo, J.
    Mosnier, A.
    Ng, V.
    Vanhems, P.
    Fisman, D. N.
    CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (09) : 1257.e1 - 1257.e7
  • [2] Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study
    Simmons, Ruth D.
    Kirwan, Peter
    Beebeejaun, Kazim
    Riordan, Andrew
    Borrow, Ray
    Ramsay, Mary E.
    Delpech, Valerie
    Lattimore, Samuel
    Ladhani, Shamez
    BMC MEDICINE, 2015, 13
  • [3] Invasive meningococcal disease in older adults: current perspectives and call for action
    Weil-Olivier, Catherine
    Taha, Muhamed-Kheir
    Leng, Sean
    Dinleyici, Ener Cagri
    Bonanni, Paolo
    Moya, Elena
    Leischker, Andreas
    Yezli, Saber
    EUROPEAN GERIATRIC MEDICINE, 2024, 15 (03) : 729 - 741
  • [4] Invasive meningococcal disease
    Strelow, Vanessa L.
    Vidal, Jose E.
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2013, 71 (9B) : 653 - 658
  • [5] Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease
    Vazquez, J. A.
    Taha, M. K.
    Findlow, J.
    Gupta, S.
    Borrow, R.
    EPIDEMIOLOGY AND INFECTION, 2016, 144 (14) : 3052 - 3057
  • [6] Incidence and Prevention of Invasive Meningococcal Disease in Global Mass Gathering Events
    Muttalif, Abdul Razak
    Presa, Jessica V.
    Haridy, Hammam
    Gamil, Amgad
    Serra, Lidia C.
    Cane, Alejandro
    INFECTIOUS DISEASES AND THERAPY, 2019, 8 (04) : 569 - 579
  • [7] The Changing Epidemiology of Meningococcal Disease
    Cohn, Amanda
    MacNeil, Jessica
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2015, 29 (04) : 667 - +
  • [8] Invasive meningococcal disease in children and adults in a tertiary level hospital. Recent epidemiology and prognostic factors
    Maturana Martinez, Daniela
    Aguilera-Alonso, David
    Garcia Mancebo, Julia
    Luisa Navarro, Maria
    Hernandez Sampelayo, Teresa
    Rincon Lopez, Elena Maria
    Santiago-Garcia, Begona
    Saavedra-Lozano, Jesus
    Santos, Mar
    Cercenado, Emilia
    ANALES DE PEDIATRIA, 2019, 91 (05): : 296 - 306
  • [9] Invasive Meningococcal Disease: What We Should Know, Before It Comes Back
    Cabellos, Carmen
    Pelegrin, Ivan
    Benavent, Eva
    Gudiol, Francesc
    Tubau, Fe
    Garcia-Somoza, Dolores
    Verdaguer, Ricard
    Ariza, Javier
    Fernandez Viladrich, Pedro
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (03):
  • [10] Invasive meningococcal disease: a disease of the endothelial cells
    Coureuil, Mathieu
    Bourdoulous, Sandrine
    Marullo, Stefano
    Nassif, Xavier
    TRENDS IN MOLECULAR MEDICINE, 2014, 20 (10) : 571 - 578